Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Phase 1 Completed
62 enrolled 17 charts
AMPLIFY-201
Phase 1 Completed
25 enrolled 15 charts
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Phase 1 Completed
260 enrolled 52 charts
CNSI-Fe(II)
Phase 1 Completed
19 enrolled 47 charts
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Phase 1 Completed
185 enrolled 28 charts
A Study in People With Colorectal Cancer to Test Whether Ezabenlimab or Pembrolizumab in Combination With BI 765063 Lead to Side Effects or Delays in Surgery
Phase 1 Terminated
2 enrolled 9 charts
V941-001
Phase 1 Terminated
70 enrolled 18 charts
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.
Phase 1 Terminated
79 enrolled 42 charts
MK-8353-013
Phase 1 Terminated
111 enrolled 30 charts
KEYNOTE-651
Phase 1 Completed
116 enrolled 18 charts
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Phase 1 Terminated
23 enrolled 10 charts
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery
Phase 1 Completed
11 enrolled 26 charts
Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery
Phase 1 Completed
24 enrolled 12 charts
A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors
Phase 1 Completed
73 enrolled 18 charts
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
Phase 1 Terminated
37 enrolled 32 charts
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Phase 1 Terminated
49 enrolled 33 charts
DC Vaccine in Colorectal Cancer
Phase 1 Terminated
4 enrolled 6 charts
Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Phase 1 Completed
36 enrolled 16 charts
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
Phase 1 Terminated
24 enrolled 29 charts
Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia
Phase 1 Completed
18 enrolled 14 charts
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
Phase 1 Completed
11 enrolled 13 charts
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Phase 1 Terminated
14 enrolled 20 charts
To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer
Phase 1 Completed
20 enrolled 9 charts
Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors
Phase 1 Completed
13 enrolled 10 charts
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Phase 1 Completed
192 enrolled 29 charts
Pilot Study of GVAX in Colorectal Cancer Cells
Phase 1 Terminated
1 enrolled 7 charts
A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
Phase 1 Completed
19 enrolled 23 charts
A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab
Phase 1 Completed
104 enrolled 23 charts
Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase 1 Completed
20 enrolled 11 charts
Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal Cancer
Phase 1 Completed
19 enrolled 20 charts
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Phase 1 Completed
25 enrolled 17 charts
PICCASSO
Phase 1 Completed
20 enrolled 12 charts
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
Phase 1 Completed
18 enrolled 9 charts
SENTINEL
Phase 1 Terminated
10 enrolled 13 charts
Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening
Phase 1 Completed
183 enrolled 8 charts
MErCuRIC1
Phase 1 Completed
82 enrolled 36 charts
Dolcanatide in Preventing Colorectal Cancer in Healthy Volunteers
Phase 1 Completed
27 enrolled 7 charts
MK-1697-001
Phase 1 Terminated
22 enrolled 18 charts
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Phase 1 Terminated
3 enrolled 7 charts
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
Phase 1 Completed
236 enrolled 21 charts
PF-06671008 Dose Escalation Study in Advanced Solid Tumors
Phase 1 Terminated
28 enrolled 25 charts
A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body
Phase 1 Terminated
51 enrolled 24 charts
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
Phase 1 Completed
45 enrolled 33 charts
Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients
Phase 1 Completed
142 enrolled 28 charts
A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
24 enrolled 27 charts
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
Phase 1 Terminated
47 enrolled 12 charts
Phase I Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Participants With Colorectal Cancer (MK-0646-016)
Phase 1 Completed
20 enrolled 30 charts
Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal Cancer
Phase 1 Completed
12 enrolled 6 charts
Safety Study of PLX4032 in Patients With Solid Tumors
Phase 1 Completed
109 enrolled 39 charts